BioSig Technologies, Inc. STEX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from BioSig Technologies, Inc.’s reported figures.
Based on the most recent quarter.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s cash ratio?
- BioSig Technologies, Inc. (STEX) reported cash ratio of 2.1× in Q1 2026.
- How has BioSig Technologies, Inc.'s cash ratio changed year-over-year?
- BioSig Technologies, Inc.'s cash ratio decreased by 6.4% year-over-year, from 2.2× to 2.1×.
- What is the long-term trend for BioSig Technologies, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s cash ratio has grown at a -38.8% compound annual growth rate (CAGR), from 5.5× to 0.5×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.